Autodesk Announces Strategic Partnership with BioDapt to Expand High‑Performance Prosthetic Innovation

ADSK
February 25, 2026

Autodesk has entered into a partnership with BioDapt, a company founded by U.S. Paralympian Mike Schultz, to develop next‑generation high‑performance prosthetic systems for para athletes and the broader assistive‑device market. The collaboration will use Autodesk’s Fusion platform, an AI‑powered manufacturing cloud, to redesign and refine key components of BioDapt’s competitive prosthetic systems, with the goal of scaling the technology beyond elite sport to wider consumer and medical applications.

The alliance aligns with Autodesk’s broader strategy of embedding AI and cloud capabilities into its design and manufacturing offerings. By leveraging Fusion’s AI‑driven design, simulation, and manufacturing tools, Autodesk aims to demonstrate the value of a cloud‑based workflow in a high‑precision industry, potentially opening a new revenue stream and strengthening its position in the medical‑device and assistive‑technology space. The partnership builds on months of technical collaboration in Fusion and showcases the platform’s ability to accelerate development from concept through production.

Jeff Kinder, EVP of Design and Manufacturing at Autodesk, said, "With Autodesk Fusion, we've brought together design and make in a single, cloud‑based platform — connecting teams, data, and workflows while leveraging AI to accelerate development from concept through production. This integrated approach creates a repeatable model for high‑performance prosthetic innovation for any athlete." The quote underscores Autodesk’s confidence that its AI‑powered platform can deliver tangible performance gains for BioDapt’s prosthetic products.

The collaboration taps into a sizable assistive‑device market, with the World Health Organization estimating that millions of people worldwide require such products. By combining BioDapt’s expertise in high‑performance prosthetics with Autodesk’s AI‑enabled design platform, the partnership positions both companies to capture a growing share of the medical‑device and assistive‑technology sector, while also providing a compelling use case for Autodesk’s Fusion platform in a demanding, high‑precision industry.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.